Ledipasvir And Sofosbuvir Tablet

Ledipasvir and Sofosbuvir Tablet are antiviral medications used in combination therapy for the treatment of chronic Hepatitis C infection. This fixed-dose combination works by targeting different stages of the viral replication process of the Hepatitis C virus, helping to stop the virus from multiplying in the body.

Ledipasvir (90 mg) acts as an NS5A inhibitor that blocks a protein required for viral replication, while Sofosbuvir  (400 mg ) is a nucleotide polymerase inhibitor that interferes with the viral RNA replication process. Together, these medications provide a highly effective treatment option that can significantly reduce the viral load and may lead to a sustained virologic response, meaning the virus becomes undetectable after treatment.

Ledipasvir and Sofosbuvir tablets are typically taken once daily for a prescribed duration, depending on the patient’s condition and treatment history. This combination therapy has become a standard treatment for many patients with chronic Hepatitis C due to its high success rate and convenient oral dosing.

Product Features

• A combination of Ledipasvir and Sofosbuvir antiviral agents.
• Used for the treatment of chronic Hepatitis C infection.
• Works by blocking viral replication of the Hepatitis C virus.
• Convenient once-daily oral tablet regimen.
• High success rate in reducing viral load.
• Helps achieve a sustained virologic response with proper treatment.

How It Helps

• Stops replication of the Hepatitis C virus.
• Reduces viral load in the bloodstream.
• Helps prevent liver damage and complications.
• Improves long-term liver health.
• Supports effective antiviral treatment outcomes.